Ortho Biotech Products, LP, a Johnson & Johnson Company, markets PROCRIT® (Epoetin alfa). PROCRIT® is for anemic chemotherapy patients with most types of cancer.
Click on the image below to go to the web site maintained by
The Abramson Cancer Center of the University of Pennsylvania
is not responsible for that site's content.
I Wish You Knew
The importance of survivorship care
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!